Short Interest in Athersys Drops By 42.2% (ATHX)
Shares of Athersys (NASDAQ:ATHX) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 4,212,469 shares, a drop of 42.2% from the April 30th total of 7,284,617 shares, American Banking News.com reports. Based on an average trading volume of 1,095,448 shares, the days-to-cover ratio is presently 3.8 days. Currently, 6.5% of the shares of the stock are short sold.
A number of research firms have recently commented on ATHX. Analysts at Edison Investment Research reiterated a “neutral” rating on shares of Athersys in a research note on Tuesday, May 6th. Separately, analysts at First Analysis initiated coverage on shares of Athersys in a research note on Tuesday, April 29th. They set an “overweight” rating and a $5.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Athersys from a “neutral” rating to an “underperform” rating in a research note on Thursday, March 20th. They now have a $3.40 price target on the stock.
Athersys (NASDAQ:ATHX) opened at 1.68 on Tuesday. Athersys has a 52 week low of $1.08 and a 52 week high of $4.33. The stock’s 50-day moving average is $1.85 and its 200-day moving average is $2.82. The company’s market cap is $129.4 million.
Athersys (NASDAQ:ATHX) last released its earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.10) by $0.01. The company had revenue of $0.71 million for the quarter, compared to the consensus estimate of $0.66 million. The company’s quarterly revenue was up 116.9% on a year-over-year basis. Analysts expect that Athersys will post $-0.40 EPS for the current fiscal year.
Athersys, Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.